RecruitingNCT06718283
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients:Correlation With Disease Activity and Chronic Organ Damage in These Patients
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients : Correlation With Disease Activity and Chronic Organ Damage in These Patients
Sponsor
Sohag University
Enrollment
50 participants
Start Date
Nov 30, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The study aim to evaluate the relationship between some important hematologic indices in juvenile lupus erythematosus patients and if these indices may be use as markers of disease acitivity in these patients or not ,also evaluate the relationship with these markers and chronic organ damage index
Eligibility
Max Age: 18 Years
Inclusion Criteria2
- patients who fillful 2012 SLICC criteria or 2019 ACR/EULAR criteria of systemic lupus erythematosus
- Age of patients at disease onset before 18 years
Exclusion Criteria2
- Adult onset disease ( age at disease onset after 18 years
- Any other chronic inflamatory disorders or other autoimmune diseases
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06718283